Stocks Merck & Co Inc

More

  • The non-binding recommendation could clear the way for the cheaper medication from Celltrion, which would only be the second in a new class of quasi-generic biotech drugs to reach the U.S. market. After nine hours of discussion the FDA panel of outside experts voted 21-3 in favor of approval for all the diseases currently indicated on Remicade's label.

  • Nasdaq sheds 3% amid massive tech sell-off Saturday, 6 Feb 2016 | 9:02 AM ET
    A trader works on the floor of the New York Stock Exchange.

    Stocks close sharply lower amid a massive drop in technology stocks and concerns the Fed may raise rates this year.

  • Merck and Chipotle are big market movers Wednesday, 3 Feb 2016 | 4:41 PM ET

    NEW YORK— Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq stock market:. Merck& Co., down 36 cents to $50.05. Chipotle Mexican Grill Inc., down $13.93 to $461.74.

  • Dow, S&P stage sharp turnaround as oil rises 8% Wednesday, 3 Feb 2016 | 4:13 PM ET
    Traders work on the floor of the New York Stock Exchange.

    U.S. stocks closed mostly higher on Wednesday, with the Dow and S&P completing a massive comeback spurred by a surge in oil.

  • Futures higher after ADP jobs report; oil eyed Wednesday, 3 Feb 2016 | 9:00 AM ET
    Traders work on the floor of the New York Stock Exchange.

    U.S. stock index futures pointed to a mostly higher open on Wednesday after a better-than-expected ADP jobs report.

  • Early movers: CMCSA, GM, MRK, MRVL & more Wednesday, 3 Feb 2016 | 7:58 AM ET
    Traders work on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Wall Street gets a boost, again driven by oil Wednesday, 3 Feb 2016 | 7:27 AM ET
    Traders work on the floor of the New York Stock Exchange

    U.S. stock futures were higher this morning, following oil prices which were rising in early trading. The Dow dropped nearly 300 points Tuesday as U.S. crude tanked 5.5 percent.

  • Merck& Co. posted an 87 percent drop in fourth-quarter profit compared with last year when the drugmaker had a huge gain from the sale of consumer health business. It beat Wall Street profit forecasts, but came up short on revenue. "This is not business as usual, not in the U.S. and not globally," said analyst Steve Brozak, president of WBB Securities, adding, "Merck gets it."

  • Business events scheduled for Wednesday Tuesday, 2 Feb 2016 | 1:19 PM ET

    WASHINGTON— Institute for Supply Management releases its service sector index for January, 10 a.m. Eastern. Comcast Corp. reports earnings before the market open. General Motors Co. reports earnings before the market open.

  • Earnings, jobs, central banks to drive stocks Friday, 29 Jan 2016 | 6:57 PM ET
    Traders work on the floor of the New York Stock Exchange.

    Stocks enter the coming week on better footing, with economic data and earnings that could determine whether the economy is slowing.

  • Business events scheduled for the coming month Friday, 29 Jan 2016 | 2:03 PM ET

    WASHINGTON— Commerce Department releases personal income and spending for December, 8:30 a.m.; Institute for Supply Management releases its manufacturing index for January, 10 a.m.; Commerce Department releases construction spending for December, 10 a.m.. BERLIN— Germany's Federal Labor Agency releases January unemployment figures for Europe's biggest...

  • Business events scheduled for the coming week Friday, 29 Jan 2016 | 1:22 PM ET

    WASHINGTON— Commerce Department releases personal income and spending for December, 8:30 a.m.; Institute for Supply Management releases its manufacturing index for January, 10 a.m.; Commerce Department releases construction spending for December, 10 a.m.. BERLIN— Germany's Federal Labor Agency releases January unemployment figures for Europe's biggest...

  • TRENTON, N.J.— Patients with hepatitis C have yet another advanced treatment option, as the Food and Drug Administration on Thursday approved a new once-a-day pill developed by drugmaker Merck. The FDA said Merck can begin marketing Zepatier for patients with two of the subtypes the liver-destroying virus, types 1 and 4. Merck& Co. said the price will be $54,600...

  • Zika epidemic on US doorstep spurs vaccine hunt Thursday, 28 Jan 2016 | 7:40 AM ET

    The rapid spread of the zika virus has spurred the hunt for a cure, but the financial incentive and likely length of time for a vaccine are unclear.

  • Your first trade for Thursday Wednesday, 27 Jan 2016 | 6:32 PM ET

    The "Fast Money" traders give their final trades of the day.

  • Trading struggling biotech: 4 stocks to watch Monday, 11 Jan 2016 | 7:17 PM ET
    A Merck sign in front of the company's building in Summit, New Jersey.

    Biotech stocks endured a rough Monday, and struggles may continue throughout the year for the high-growth sector, one trader said.

  • Lightning Round: Don't touch this yet Monday, 11 Jan 2016 | 7:09 PM ET
    Mad Money Lightning Round

    Jim Cramer provides his take on caller favorite stocks, including this popular technology play that can't be touched.

  • Rough start to 2016? Here's how to trade it Friday, 8 Jan 2016 | 7:00 AM ET
    Traders work on the floor of the New York Stock Exchange.

    China volatility. Oil selling off. Geopolitical tensions. The year did not get off to a good start for investors.

  • Jan 7- Dynavax Technologies Corp said its experimental hepatitis B vaccine was found to be safe and effective in a late-stage study, paving the way for the company to resubmit its marketing application. The earlier marketing application for the vaccine, HEPLISAV-B, was rejected in February 2013 by the U.S. Food and Drug Administration, which sought additional...

  • Don't let big Dow drop turn you off these stocks Monday, 4 Jan 2016 | 10:56 AM ET
    A trader's reflection on a screen at the New York Stock Exchange.

    There's a case to be made for the Dogs of the Dow, even as stocks start 2016 down. They offer yields that can pay off a mortgage.